Press Releases : Assembly Biosciences, Inc.

Press Releases

Sep 01, 2021	Assembly Bio Announces Decision to Discontinue Clinical Development of ABI-H2158	View HTML PDF Version
Aug 18, 2021	Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advancement Into Clinical Development	View HTML PDF Version
Aug 05, 2021	Assembly Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights	View HTML PDF Version
Aug 03, 2021	Assembly Bio Announces Key Promotions to Leadership Team	View HTML PDF Version
Jul 20, 2021	Nobel Laureate Dr. Michael Houghton Appointed to Assembly Biosciences Board of Directors	View HTML PDF Version
Jul 02, 2021	Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	View HTML PDF Version
Jun 23, 2021	Assembly Biosciences Presents Data from HBV Core Inhibitor Programs at the International Liver Congress™ EASL 2021	View HTML PDF Version
Jun 09, 2021	Assembly Biosciences to Present Data from HBV Core Inhibitor Programs at The International Liver Congress™ EASL 2021	View HTML PDF Version
Jun 04, 2021	Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	View HTML PDF Version
May 24, 2021	Dr. Lisa Johnson-Pratt Joins Assembly Biosciences Board of Directors	View HTML PDF Version

Shareholder Tools

Search Investors